1. Home
  2. ELUT vs CODA Comparison

ELUT vs CODA Comparison

Compare ELUT & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • CODA
  • Stock Information
  • Founded
  • ELUT 2015
  • CODA 1994
  • Country
  • ELUT United States
  • CODA United States
  • Employees
  • ELUT N/A
  • CODA N/A
  • Industry
  • ELUT Medical Specialities
  • CODA Industrial Machinery/Components
  • Sector
  • ELUT Health Care
  • CODA Industrials
  • Exchange
  • ELUT Nasdaq
  • CODA Nasdaq
  • Market Cap
  • ELUT 94.0M
  • CODA 92.5M
  • IPO Year
  • ELUT 2020
  • CODA N/A
  • Fundamental
  • Price
  • ELUT $2.08
  • CODA $6.94
  • Analyst Decision
  • ELUT Strong Buy
  • CODA Strong Buy
  • Analyst Count
  • ELUT 2
  • CODA 1
  • Target Price
  • ELUT $8.00
  • CODA $11.00
  • AVG Volume (30 Days)
  • ELUT 38.7K
  • CODA 46.2K
  • Earning Date
  • ELUT 05-08-2025
  • CODA 06-11-2025
  • Dividend Yield
  • ELUT N/A
  • CODA N/A
  • EPS Growth
  • ELUT N/A
  • CODA 61.24
  • EPS
  • ELUT N/A
  • CODA 0.34
  • Revenue
  • ELUT $23,711,000.00
  • CODA $21,064,685.00
  • Revenue This Year
  • ELUT $39.35
  • CODA $11.64
  • Revenue Next Year
  • ELUT $61.26
  • CODA $14.53
  • P/E Ratio
  • ELUT N/A
  • CODA $20.08
  • Revenue Growth
  • ELUT N/A
  • CODA 15.63
  • 52 Week Low
  • ELUT $1.79
  • CODA $5.76
  • 52 Week High
  • ELUT $5.24
  • CODA $9.89
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 43.18
  • CODA 58.52
  • Support Level
  • ELUT $1.79
  • CODA $6.41
  • Resistance Level
  • ELUT $2.44
  • CODA $6.95
  • Average True Range (ATR)
  • ELUT 0.22
  • CODA 0.38
  • MACD
  • ELUT 0.00
  • CODA 0.05
  • Stochastic Oscillator
  • ELUT 46.27
  • CODA 78.78

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About CODA Coda Octopus Group Inc. Common stock

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. It operates in two segments: Marine Technology Business and Marine Engineering Business. The Technology Business develops proprietary solutions for both the commercial and defense subsea market. Its solutions include hardware and software for Geophysical Systems, Motion & Positioning Systems, and Real-Time Volumetric Imaging Sonar. The Engineering Business segment provides engineering services to a range of clients in the defense markets. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Marine Technology Business segment.

Share on Social Networks: